BioMarin’s Roctavian Continues to Shine In Hemophilia A Despite Commercial Woes

Positive Data From Longer-Term Study

Brisbane, CA, USA - Mar 1, 2020: The BioMarin logo seen at American biotechnology company BioMarin Pharmaceutical Inc.'s office in Brisbane, California.
BioMarin • Source: Shutterstock

More from Clinical Trials

More from R&D